MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. (Q53341906)
Jump to navigation
Jump to search
scientific article published in September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. |
scientific article published in September 2006 |
Statements
MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. (English)
1 reference
Naoki Ohmiya
1 reference
Nobuyuki Mabuchi
1 reference
Akihiro Itoh
1 reference
Yoshiki Hirooka
1 reference
Yasumasa Niwa
1 reference
Hidemi Goto
1 reference
1 September 2006
1 reference
24
1 reference
27
1 reference
4434-4440
1 reference
Identifiers
1 reference